Study
|
Year
|
Design
|
Sample Size
|
Mean age(years)
|
Tumor Size(cm)
|
BMI (kg/m2)
|
Neoadjuvant therapy (sample size)
|
---|
LPD
|
OPD
|
LPD
|
OPD
|
LPD
|
OPD
|
LPD
|
OPD
|
LPD
|
OPD
|
---|
Croome
|
2014
|
P,S
|
108
|
214
|
66.6
|
65.4
|
3.3a
|
3.3a
|
27.4a
|
27.2a
|
12
|
30
|
Speicher
|
2014
|
R,S
|
25
|
84
|
61
|
64
|
2b
|
3b
|
24b
|
25b
|
9
|
26
|
Sharpe
|
2015
|
R,M
|
384
|
4037
|
65.6
|
66.1
|
3.2a
|
3.3a
|
NA
|
NA
|
NA
|
NA
|
Stauffer
|
2016
|
P,S
|
58
|
193
|
66.9
|
68.9
|
2.5b
|
3.5b
|
25.9b
|
25.6b
|
NA
|
NA
|
Champman
|
2017
|
R,M
|
248
|
1520
|
79.6
|
79.5
|
NA
|
NA
|
NA
|
NA
|
175
|
83
|
Kantor
|
2017
|
R,M
|
828
|
7385
|
65.9
|
65.7
|
NA
|
NA
|
NA
|
NA
|
642
|
5714
|
Chen
|
2018
|
R,S
|
47
|
55
|
63
|
66
|
NA
|
AN
|
24a
|
22.7a
|
NA
|
NA
|
Dokmak
|
2015
|
P,S
|
46
|
46
|
60
|
63
|
2.82a
|
2.51a
|
22.6a
|
26.4a
|
NA
|
NA
|
- P prospective study S single center R retrospective study M mutli-centers NA not avaliable BMI body mass index aMean bMedian